MSV
GILD icon

MN Services Vermogensbeheer’s Gilead Sciences GILD Stock Holding History

MN Services Vermogensbeheer’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.7M Buy
485,739
+2,900
+0.6% +$406K 0.45% 44
2025
Q4 		$59.3M Buy
482,839
+8,284
+2% +$1.01M 0.36% 60
2025
Q3 		$52.7M Buy
474,555
+8,500
+2% +$966K 0.34% 66
2025
Q2 		$51.7M Buy
466,055
+9,600
+2% +$1.02M 0.36% 58
2025
Q1 		$51.1M Sell
456,455
-35,700
-7% -$3.68M 0.4% 54
2024
Q4 		$45.5M Buy
492,155
+11,300
+2% +$1.02M 0.31% 64
2024
Q3 		$40.3M Sell
480,855
-11,900
-2% -$908K 0.28% 77
2024
Q2 		$33.8M Sell
492,755
-11,100
-2% -$741K 0.24% 87
2024
Q1 		$36.9M Sell
503,855
-87,800
-15% -$6.75M 0.27% 82
2023
Q4 		$47.9M Sell
591,655
-18,900
-3% -$1.47M 0.43% 63
2023
Q3 		$45.8M Buy
610,555
+10,900
+2% +$838K 0.44% 63
2023
Q2 		$46.2M Sell
599,655
-25,000
-4% -$1.99M 0.43% 63
2023
Q1 		$51.8M Buy
624,655
+18,900
+3% +$1.57M 0.53% 49
2022
Q4 		$52M Sell
605,755
-91,200
-13% -$7.22M 0.58% 45
2022
Q3 		$43M Sell
696,955
-40,100
-5% -$2.53M 0.45% 53
2022
Q2 		$45.6M Sell
737,055
-164,600
-18% -$10.2M 0.42% 56
2022
Q1 		$53.6M Sell
901,655
-57,500
-6% -$3.68M 0.36% 72
2021
Q4 		$69.6M Buy
959,155
+17,800
+2% +$1.23M 0.41% 62
2021
Q3 		$65.8M Buy
941,355
+19,900
+2% +$1.4M 0.41% 65
2021
Q2 		$53.5M Buy
+921,455
New +$61.5M 0.42% 63
2020
Q4 		$64.7M Buy
1,111,255
+12,800
+1% +$772K 0.46% 61
2020
Q3 		$69.4M Buy
1,098,455
+21,600
+2% +$1.5M 0.55% 47
2020
Q2 		$82.9M Sell
1,076,855
-15,800
-1% -$1.21M 0.71% 39
2020
Q1 		$81.7M Sell
1,092,655
-68,700
-6% -$4.75M 0.91% 31
2019
Q4 		$75.5M Buy
1,161,355
+36,700
+3% +$2.39M 0.64% 41
2019
Q3 		$71.3M Buy
1,124,655
+471,725
+72% +$30.8M 0.66% 41
2019
Q2 		$44.1M Sell
652,930
-68,000
-9% -$4.47M 0.52% 41
2019
Q1 		$46.9M Buy
720,930
+6,500
+0.9% +$432K 0.54% 41
2018
Q4 		$39.1M Buy
714,430
+505,855
+243% +$35.4M 0.59% 41
2018
Q3 		$16.1M Sell
208,575
-700
-0.3% -$52.9K 0.38% 57
2018
Q2 		$14.8M Buy
209,275
+3,700
+2% +$261K 0.37% 56
2018
Q1 		$15.5M Buy
205,575
+2,300
+1% +$183K 0.4% 51
2017
Q4 		$12.1M Sell
203,275
-12,200
-6% -$926K 0.38% 54
2017
Q3 		$17.5M Sell
215,475
-400
-0.2% -$30.6K 0.46% 43
2017
Q2 		$15.3M Buy
215,875
+180,694
+514% +$12M 0.42% 45
2017
Q1 		$2.23M Buy
35,181
+1,021
+3% +$71.8K 0.43% 45
2016
Q4 		$2.32M Sell
34,160
-294
-0.9% -$21.9K 0.47% 43
2016
Q3 		$2.73M Sell
34,454
-238
-0.7% -$19.3K 0.54% 38
2016
Q2 		$2.6M Sell
34,692
-1,431
-4% -$127K 0.6% 37
2016
Q1 		$2.91M Buy
+36,123
New +$3.26M 0.68% 30

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MN Services Vermogensbeheer's GILD Position: Q1 2026 in Review

MN Services Vermogensbeheer increased its Gilead Sciences (GILD) stake by 0.6% in Q1 2026, buying an estimated $406K and bringing the position to 485,739 shares worth $67.7M. The position accounts for 0.45% of the portfolio, ranked #44.

MN Services Vermogensbeheer first reported a position in GILD in Q1 2016 and has held it in 40 quarters since. The position peaked at $82.9M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • MN Services Vermogensbeheer held 485,739 shares of Gilead Sciences worth $67.7M as of Q1 2026.
  • MN Services Vermogensbeheer bought 2,900 Gilead Sciences shares in Q1 2026, an estimated $406K.
  • Gilead Sciences made up 0.45% of MN Services Vermogensbeheer's portfolio in Q1 2026, its #44 holding.
  • MN Services Vermogensbeheer first reported a position in Gilead Sciences in Q1 2016 and has held it in 40 quarters since.
  • MN Services Vermogensbeheer's Gilead Sciences position peaked at $82.9M in Q2 2020.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.